Compare MTL Cannabis Corp. with Similar Stocks
Stock DNA
Other Agricultural Products
CAD 69 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
1.20
-12.27%
2.94
Revenue and Profits:
Net Sales:
17 Million
(Quarterly Results - Dec 2025)
Net Profit:
1 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-32.94%
0%
-32.94%
6 Months
-9.52%
0%
-9.52%
1 Year
72.73%
0%
72.73%
2 Years
115.09%
0%
115.09%
3 Years
1528.57%
0%
1528.57%
4 Years
1528.57%
0%
1528.57%
5 Years
-45.71%
0%
-45.71%
MTL Cannabis Corp. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
60.86%
EBIT Growth (5y)
29.21%
EBIT to Interest (avg)
-2.73
Debt to EBITDA (avg)
2.38
Net Debt to Equity (avg)
1.10
Sales to Capital Employed (avg)
1.68
Tax Ratio
24.47%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.02%
ROCE (avg)
5.78%
ROE (avg)
0.11%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.94
EV to EBIT
9.28
EV to EBITDA
6.24
EV to Capital Employed
1.88
EV to Sales
1.19
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
20.28%
ROE (Latest)
-12.27%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
Mildly Bearish
Shareholding Snapshot : Apr 2020
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.02%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
Dec'25
Sep'25
Change(%)
Net Sales
17.20
20.60
-16.50%
Operating Profit (PBDIT) excl Other Income
2.80
1.30
115.38%
Interest
1.10
1.40
-21.43%
Exceptional Items
0.00
0.10
-100.00%
Consolidate Net Profit
0.70
-8.30
108.43%
Operating Profit Margin (Excl OI)
102.50%
6.30%
9.62%
USD in Million.
Net Sales
QoQ Growth in quarter ended Dec 2025 is -16.50% vs -0.48% in Sep 2025
Consolidated Net Profit
QoQ Growth in quarter ended Dec 2025 is 108.43% vs 0.00% in Sep 2025
Annual Results Snapshot (Consolidated) - Mar'25
Mar'25
Mar'24
Change(%)
Net Sales
84.10
65.30
28.79%
Operating Profit (PBDIT) excl Other Income
29.50
11.40
158.77%
Interest
7.30
5.60
30.36%
Exceptional Items
-7.90
-0.60
-1,216.67%
Consolidate Net Profit
6.80
2.40
183.33%
Operating Profit Margin (Excl OI)
283.70%
114.20%
16.95%
USD in Million.
Net Sales
Not Applicable: The company has declared_date for only one period
Consolidated Net Profit
Not Applicable: The company has declared_date for only one period
About MTL Cannabis Corp. 
MTL Cannabis Corp.
Other Agricultural Products
Canada House Cannabis Group Inc., formerly Canada House Wellness Group Inc, is a Canada-based cannabis company engaged in providing cannabinoid therapy products and services. The Company's operated subsidiaries are: Canada House Clinics, Knalysis Technologies Inc and Abba Medix Corp. Its Canada House Clinics is focused on treating complex health issues through assessments, ongoing support, and data-driven treatment plans that are monitored by cannabinoid therapy educators. Its Knalysis Technologies, is a provider of fully customizable, cloud-based software that links physician, provider, and patient to data that supports treatment with medical cannabis. Its Abba Medix Corp is engaged in producing cannabis genetics and products in a fully integrated seed-to-sale vertical and links the growth operations, patient services, and offers artificial intelligence (AI) assisted data reporting solutions.






